Global Softgel Capsules Market Size Report, 2022 - 2030
Softgel Capsules Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030

Softgel Capsules Market Share, Size, Trends, Industry Analysis Report, By Type (Gelatin-based/Animal-based, Non-animal-based), By Application, By Manufacturers, By Region; Segment Forecast, 2022 - 2030

  • Published Date:Jan-2022
  • Pages: 110
  • Format: PDF
  • Report ID: PM2200
  • Base Year: 2021
  • Historical Data: 2018 - 2020

Report Outlook

The global softgel capsules market was valued at USD 4.88 billion in 2021 and is expected to grow at a CAGR of 9.2% during the forecast period. The rising occurrence of chronic diseases such as cardiovascular diseases coupled with the growing number of clinical trials for the softgel capsules is propelling the market demand. In addition, increasing production of gelatin is directly influencing the industry development as softgel capsules are derived using gelatin which is the chief raw material. Furthermore, growing investments by the leading players on the R&D activities, as well as rising inclination towards the natural products among the population, is boosting the industry growth in the forthcoming years.

Softgel Capsules Market SizeKnow more about this reportrequest for sample pages

The outbreak of the COVID-19 has shown a major impact on every industry due to the imposition of lockdowns and execution of the social distancing norms across various regions. During this pandemic, numerous companies-initiated research to develop oral vaccines, and five companies globally are developing orally administered vaccines along with two organizations, Vaxart and Immunity Bío have transferred to the clinical trial stage.

Catalent- one of the leading softgel companies, collaborated with a chief clinical-stage immunotherapy company. This collaboration aims to meet the growing requirements for oral vaccines. Moreover, several studies have been undertaken to check the administration of vitamin-D tablets decreases the severity of mild and severe respiratory discomfort linked with the SAR-Cov-2 virus infection. Therefore, this widespread coronavirus exhibits a positive impact on the industry growth. Furthermore, escalating demand for vitamins and mineral supplements for boosting the immune system is further fueling the softgel capsules market growth worldwide.

Softgel Capsules Market 2030

Know more about this reportrequest for sample pages

Industry Dynamics 

Growth Drivers
The penetration of the emerging and innovative technologies by the companies is acting as a major impelling factor for the global industry demand. Producers are initiating a wide range of R&D activities to offer exclusive empty softgel capsules, which are highly adaptable as well as convenient for cosmeceutical, pharmaceutical, nutraceutical, and further industry segments. The empty softgel capsules are gaining high popularity across the pharmaceutical and nutraceutical industries. The exclusive properties of empty softgel capsules for different formulations like solid and liquid dosage type and easy-to-use features at the same time as managing drugs orally or through inhalation routes are significantly propelling the demand for the softgel capsules market.

For instance, in October 2020, Catalent proclaimed the introduction of new OptiGel DR technology, which assists in the formulation and production of the enteric release soft gels. Moreover, various softgel capsule products are coming into the industry with better-quality capsule features, such as hydrophilic sandwich (HS) pills, crew caps, duo caps, etc., also spur the industry demand. Furthermore, companies are advancing capsules using a blend of porcine and bovine gelatin because of their exceptional properties. Gelatin derived from the bovine may improve capsule decisiveness, and porcine offers flexibility and clarity attribute to the formulation. Therefore, these factors boost the softgel capsules market growth across the globe.

Report Segmentation

The market is primarily segmented on the basis of type, application, manufacturers, and region.

By Type

By Application

By Manufacturers

By Region

  • Gelatin based/Animal-based
  • Non-animal based
  • Antacid and anti-flatulent preparations
  • Anti-anemic preparations
  • Anti-inflammatory drugs
  • Antibiotic and antibacterial drugs
  • Cough and cold preparations
  • Health supplement
  • Vitamin and dietary supplement
  • Pregnancy
  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Contract Manufacturing Organization
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this reportrequest for sample pages

Insight by Application

The vitamins and dietary supplements segment are accounted for the largest revenue in the global industry and leads the market with the largest revenue shares. The demand for dietary supplements is growing majorly for the treatment & prevention of some diseases is leading the segment demand. In addition, softgel capsules are the foremost formulation alternative, as they guard against UV radiation and oxidation that eventually enhances its shelf life. Besides, studies proposed that vitamins, when administered in softgel capsule form, are rapidly immersed into the bloodstream in comparison to the tablet formulation. Thereby, these benefits of vitamins are primarily penetrated into the form of softgel capsules, which, in turn, impels the segment demand across the global industry.

Moreover, the health segment is expected to demonstrate the highest CAGR, owing to the rising inclination towards healthy lifestyles for balancing health and boosting the immune system majorly at the time of this pandemic. Also, increasing acceptance of tasteless medication, as well as rising responsiveness for the pre-and post-natal pills, is attributed to demand for softgel capsules. Hence, these factors are gaining a huge prominence in the market that propels the industry demand in the impending years.

Geographic Overview

Geographically, North America is accounted with the highest shares in the global market in 2021. The R&D and high expenditure by the leading players, as well as the availability of superior technologies, presence of leading players, and rising investments in R&D to diversify product portfolio are the factors that are significantly contributing to the industry growth across the region. Moreover, the growing awareness for health & fitness among the population coupled with the presence of leading pharma companies in North America is driving the regional industry demand.

Moreover, Asia Pacific is also expected to rise at the highest growth rate in the global market over the forthcoming years. The increasing number of generic medicine manufacturers majorly across India and China, as well as growing economic conditions, acts as a catalyzing factor for the market growth. In addition, escalating demand for pocket-friendly therapeutics and the increasing number of contract manufacturing enterprises in APAC are the further factors that are accountable for the high market development. Furthermore, the growing medicine expenditure for maintaining health & fitness and penetration of the high-tech processing for fostering the manufacturing of softgels capsules are also anticipated to boost market demand. Therefore, rising investments in health & wellness products by the government also create lucrative opportunities for market growth in the near future.

Competitive Insight

Some of the major players operating in the global market include Aenova, Capsugel, Captek, Catalent, Elnova Pharma, Eurocaps, Fuji Capsules Co Ltd, Guangdong Yichao Biological Co., Ltd, Hunan ER-KANG Pharmaceutical Co Ltd, Patheon, Procaps Laboratories, Sirio Pharma, Soft gel Technologies Inc.

Softgel Capsules Market Report Scope

Report Attributes


Market size value in 2021

USD 4.88 billion

Revenue forecast in 2030

USD 10.69 billion


9.2% from 2022 - 2029

Base year


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2022 to 2030

Segments covered

By Type, By Application, By Manufactures, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Key Companies

Aenova, Capsugel, Captek, Catalent, Elnova Pharma, Eurocaps, Fuji Capsules Co Ltd, Guangdong Yichao Biological Co., Ltd, Hunan ER-KANG Pharmaceutical Co Ltd, Patheon, Procaps Laboratories, Sirio Pharma, Soft gel Technologies Inc.